What Happened?
San Diego, CA-based GlySens Appointed William Markle as Chief Executive Officer
About the Company
GlySens Incorporated is a privately held corporation devoted to developing the world`s first truly long term continuous glucose monitoring system. Our goal: to enable easy, unobtrusive, worry-free diabetes control that empowers users by providing the information they need to optimize care, while freeing them to live life on their own terms.
About the Person
William (Bill) Markle is President and CEO of GlySens. Mr. Markle has a 30-year track record of successful product and global market development, clinical evaluation, and visionary leadership in the medical device field. He was formerly founder, President, and CEO of GluMetrics, Inc. At GluMetrics, he directed the successful development of continuous real-time sensing technology for intravascular glucose monitoring in the intensive care and operating room environment. Previously, he held senior executive positions in marketing and business development at Tensys Medical and Masimo Corporation, and related positions at Baxter Edwards Critical Care and American Hospital Supply. Mr. Markle is an MBA graduate of Pepperdine University and an engineering graduate of Duke University. He is a named inventor on numerous issued U.S. patents and published applications.
Info Source
Press Release
Short Profile